Main Takeaway: Walter Kernan, MD interviews Richard Bernstein, MD, primary investigator of the study, "Cryptogenic Stroke and Underlying Atrial ... Merit Cudkowicz, MD, MSc, research scientists from Biohaven Pharmaceuaticals and regimen co-leads, Jinsy Andrews, MD, MSc ...

Dr Healey On The Assert Ii Trial -

Walter Kernan, MD interviews Richard Bernstein, MD, primary investigator of the study, "Cryptogenic Stroke and Underlying Atrial ... Merit Cudkowicz, MD, MSc, research scientists from Biohaven Pharmaceuaticals and regimen co-leads, Jinsy Andrews, MD, MSc ... Research scientists from Clene Nanomedicine presented the rationale and science behind CNM-Au8, one of the study drugs ...

Important details found

  • Walter Kernan, MD interviews Richard Bernstein, MD, primary investigator of the study, "Cryptogenic Stroke and Underlying Atrial ...
  • Merit Cudkowicz, MD, MSc, research scientists from Biohaven Pharmaceuaticals and regimen co-leads, Jinsy Andrews, MD, MSc ...
  • Research scientists from Clene Nanomedicine presented the rationale and science behind CNM-Au8, one of the study drugs ...
  • After publication of the two landmark studies NOAH-AFNET 6 and ARTESIA, their principal investigators - Prof.
  • In this industry-focused webinar, Mass General Neurology researchers offer an introduction to the

Why this topic is useful

A structured page helps reduce disconnected snippets by grouping the main subject with context, examples, and nearby entries.

Sponsored

Frequently Asked Questions

Is the information always complete?

Not always. Some topics may need verification from official or primary sources.

How should readers use this information?

Use it as a starting point, then open related pages for more specific details.

What should readers check next?

Readers should check related pages, official references, or updated sources when details matter.

Visual References

Dr. Healey on the ASSERT II trial
CRYSTAL AF
HEALEY ALS Platform Trial Mechanism of Action & Science: Verdiperstat
HEALEY ALS Platform Trial: Mechanism of Action & Science webinar: CNM-Au8
Device-detected A Fib: NOAH-AFNET 6 & ARTESIA - Prof. Jeff Healey,  Prof. Paulus Kirchhof
HEALEY ALS Platform Trial Informational Industry Webinar: April 14, 2022.
HEALEY ALS Platform Trial Webinar: February 22, 2024 | Genetics with Dr. Mark Garret
Hot Topics of AF Screening and Subclinical AF - Grand Rounds with Jeff Healey, MD
HEALEY ALS Platform Trial April 1 Weekly Q&A
HEALEY ALS Platform Trial Webinar: April 23, 2026 | CSF Collection in Research
Sponsored
View Full Details
Dr. Healey on the ASSERT II trial

Dr. Healey on the ASSERT II trial

Read more details and related context about Dr. Healey on the ASSERT II trial.

CRYSTAL AF

CRYSTAL AF

Walter Kernan, MD interviews Richard Bernstein, MD, primary investigator of the study, "Cryptogenic Stroke and Underlying Atrial ...

HEALEY ALS Platform Trial Mechanism of Action & Science: Verdiperstat

HEALEY ALS Platform Trial Mechanism of Action & Science: Verdiperstat

Merit Cudkowicz, MD, MSc, research scientists from Biohaven Pharmaceuaticals and regimen co-leads, Jinsy Andrews, MD, MSc ...

HEALEY ALS Platform Trial: Mechanism of Action & Science webinar: CNM-Au8

HEALEY ALS Platform Trial: Mechanism of Action & Science webinar: CNM-Au8

Research scientists from Clene Nanomedicine presented the rationale and science behind CNM-Au8, one of the study drugs ...

Device-detected A Fib: NOAH-AFNET 6 & ARTESIA - Prof. Jeff Healey,  Prof. Paulus Kirchhof

Device-detected A Fib: NOAH-AFNET 6 & ARTESIA - Prof. Jeff Healey, Prof. Paulus Kirchhof

After publication of the two landmark studies NOAH-AFNET 6 and ARTESIA, their principal investigators - Prof. Jeff

HEALEY ALS Platform Trial Informational Industry Webinar: April 14, 2022.

HEALEY ALS Platform Trial Informational Industry Webinar: April 14, 2022.

In this industry-focused webinar, Mass General Neurology researchers offer an introduction to the

HEALEY ALS Platform Trial Webinar: February 22, 2024 | Genetics with Dr. Mark Garret

HEALEY ALS Platform Trial Webinar: February 22, 2024 | Genetics with Dr. Mark Garret

Read more details and related context about HEALEY ALS Platform Trial Webinar: February 22, 2024 | Genetics with Dr. Mark Garret.

Hot Topics of AF Screening and Subclinical AF - Grand Rounds with Jeff Healey, MD

Hot Topics of AF Screening and Subclinical AF - Grand Rounds with Jeff Healey, MD

Read more details and related context about Hot Topics of AF Screening and Subclinical AF - Grand Rounds with Jeff Healey, MD.

HEALEY ALS Platform Trial April 1 Weekly Q&A

HEALEY ALS Platform Trial April 1 Weekly Q&A

Sabrina Paganoni, MD, PhD and Merit Cudkowicz, MD, MSc presented this week's updates on the

HEALEY ALS Platform Trial Webinar: April 23, 2026 | CSF Collection in Research

HEALEY ALS Platform Trial Webinar: April 23, 2026 | CSF Collection in Research

Read more details and related context about HEALEY ALS Platform Trial Webinar: April 23, 2026 | CSF Collection in Research.